Understanding the Side Effects of SGB: What Patients Need to Know

Every medical intervention presents a spectrum of outcomes - not just beneficial effects, but also potential physiological responses that warrant careful consideration and informed consent. Stellate Ganglion Block (SGB) therapy is becoming more popular for treating PTSD, anxiety, and depression, but you need to understand everything about how it affects your body.

This review will carefully look at all known side effects, explain why they happen in your body, and discuss what you should think about when deciding if this treatment is right for you.

‍

Physiological Mechanism Review - What Is SGB?

‍

Stellate Ganglion Block involves the precise administration of local anesthetic adjacent to the stellate ganglion - a collection of sympathetic nerve cell bodies located in the cervical region. This neural structure serves as a critical regulatory node in the sympathetic nervous system, which governs the body's stress response mechanisms.

By temporarily interrupting neural transmission through this ganglion, SGB can modulate sympathetic outflow, potentially disrupting the cycle of hyperarousal characteristic of trauma-related conditions. The technique has an established medical history spanning over a century, originally developed for vascular and pain disorders before its more recent application to psychiatric conditions.

‍

Expected Physiological Responses

‍

Clinical documentation indicates that most patients tolerate the procedure well, but certain predictable physiological responses frequently occur during the immediate post-procedural period. These manifestations are typically transient and self-limiting, resolving as the anesthetic agent metabolizes.

‍

1. Horner's Syndrome: A Clinical Indicator

Horner's syndrome represents the most visibly apparent and diagnostically significant response to successful stellate ganglion blockade. This syndrome manifests as a constellation of signs resulting from interruption of sympathetic innervation to facial structures:

• Ptosis (drooping of the upper eyelid)
• Miosis (pupillary constriction)
• Conjunctival injection (mild redness of the eye)
• Facial vasodilation (warmth and flushing on the ipsilateral side)

While potentially concerning in appearance, these manifestations are clinically benign and serve as confirmation of successful sympathetic blockade. Resolution typically occurs within 4-6 hours as the anesthetic effect diminishes.

‍

2. Phonation Alterations

Transient dysphonia or hoarseness may develop following the procedure due to the anatomical proximity of the recurrent laryngeal nerve to the injection site. The anesthetic solution can temporarily affect neural transmission to the vocal cord musculature, resulting in altered voice quality. This effect spontaneously resolves as the anesthetic agent clears from the affected tissues.

‍

3. Dysphagia

Mild difficulty with swallowing may occur due to the procedure's impact on neural structures involved in pharyngeal function. The complex neuromuscular coordination required for effective swallowing can be temporarily disrupted when anesthetic affects branches of the vagus and glossopharyngeal nerves in the vicinity of the injection site. This manifestation is characteristically short-lived.

Less Frequent Physiological Responses

‍

Statistical analysis of clinical data reveals several less common but documented responses:

‍

1. Orthostatic Symptoms

Some patients experience transient lightheadedness or dizziness resulting from alterations in vascular tone and autonomic regulatory function. The sympathetic nervous system plays a crucial role in maintaining blood pressure and vascular resistance; temporary blockade can induce vasodilation and relative hypotension, particularly with positional changes. Conservative measures such as gradual position changes and adequate hydration typically mitigate these effects.

2. Local Tissue Reactions

As with any percutaneous procedure, minor trauma to superficial tissues may result in:

• Localized edema
• Ecchymosis (bruising)
• Injection site tenderness

These manifestations reflect normal inflammatory responses to minor tissue disruption and resolve through standard physiological healing processes.

‍

3. Paresthesias

Occasional reports describe temporary sensory phenomena such as tingling or numbness in the upper extremity ipsilateral to the injection. These sensations result from the anesthetic's effect on sensory nerve fibers traversing the region and resolve without intervention as the anesthetic effect dissipates.

‍

4. Cephalgia

A subset of patients reports mild to moderate headache following the procedure. The pathophysiology likely involves altered cerebrovascular tone secondary to sympathetic blockade, as sympathetic fibers regulate cerebral blood flow. These headaches typically respond well to standard analgesics and hydration.

‍

Rare Adverse Events: Understanding the Risk Spectrum

‍

While serious complications occur with extremely low frequency, particularly when the procedure is performed using contemporary ultrasound-guided techniques, scientific integrity demands acknowledgment of documented risks:

‍

1. Infectious Complications

Despite rigorous aseptic technique, any breach of skin integrity theoretically increases infection risk. Published literature suggests infection rates well below 0.1% when standard sterile procedures are employed.

‍

2. Vascular Complications

The proximity of major vascular structures (carotid artery, vertebral artery, jugular vein) to the injection site creates potential for:

• Hematoma formation
• Intravascular injection
• Vascular trauma

Ultrasound guidance has substantially reduced these risks by providing real-time visualization of vascular structures during needle advancement.

‍

3. Pneumothorax

The anatomical relationship between the stellate ganglion and the pleural apex creates a theoretical risk of lung puncture. This complication occurs in significantly less than 0.5% of cases when performed by experienced practitioners using image guidance.

4. Seizure Activity

‍

Direct intravascular administration of local anesthetic may, in rare circumstances, result in sufficient systemic levels to induce central nervous system toxicity manifesting as seizure activity. Contemporary protocols emphasizing aspiration before injection, incremental administration, and concentration limits minimize this risk.

Multiple systematic reviews and meta-analyses indicate that serious complications occur in fewer than 1% of procedures when performed according to current standards of practice.

Physiological Basis of Side Effects

The majority of observed effects stem from the anatomical complexity of the cervical region and the diversity of structures in proximity to the stellate ganglion:

1. Neural Density: The region contains components of multiple cranial nerves, sympathetic chains, and brachial plexus elements.
2. Vascular Supply: Major vessels including the carotid artery, vertebral artery, and jugular vein traverse the area.
3. Tissue Diffusion: Local anesthetics necessarily spread beyond the precise target, affecting adjacent structures temporarily.

‍

The transient nature of these effects corresponds directly to the pharmacokinetic profile of the anesthetic agents employed, with complete resolution expected as metabolism and clearance occur.

‍

Post-Procedural Protocols

‍

Following SGB administration, standardized clinical monitoring typically includes:

1. Brief observation in a controlled clinical environment to detect immediate adverse reactions
2. Patient education regarding expected effects and self-monitoring parameters
3. Activity modifications including:
   
   • Limited physical exertion for 24 hours
   • Abstention from driving until complete resolution of any visual or proprioceptive effects
   • Adequate hydration to support normal physiological function
4. Clear communication pathways for reporting unexpected symptoms such as respiratory distress, severe pain, neurological changes, or signs of infection

Most patients resume normal activities within 24 hours with progressive improvement in their primary symptoms over the subsequent days.
‍

‍

The Informed Decision Framework

‍

The scientific evaluation of SGB requires balancing documented efficacy against potential physiological responses. For patients considering this intervention, comprehensive knowledge serves as the foundation for meaningful shared decision-making with healthcare providers.

‍

SGB represents a significant intervention requiring thoughtful deliberation, transparent clinical discussion, and realistic expectation-setting. The majority of patients experience only transient, manageable side effects while potentially gaining substantial symptomatic relief from conditions that have proven resistant to conventional approaches.

‍

The scientific literature continues to evolve, with ongoing research refining both the therapeutic applications and risk mitigation strategies for this promising neuromodulatory intervention.

‍